Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
JDOC
60
HOLDINGS
18%
ALSO IN CANC
CANC
55
HOLDINGS
16%
ALSO IN JDOC
SECTOR DRIFT (JDOC minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in JDOC |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.8% | 5.3% | 5.3% |
 |
NOVARTIS AG | 4.7% | 4.2% | 4.2% |
|
ABBVIE INC | 8.5% | 4.0% | 4.0% |
|
MERCK & CO. INC. | 3.6% | 5.2% | 3.6% |
|
JOHNSON & JOHNSON | 4.7% | 2.5% | 2.5% |
JDOC Overweight Relative to CANC
|
UNITEDHEALTH GROUP INC | 5.4% |
|
ABBVIE INC | 4.5% |
|
THERMO FISHER SCIENTIFIC INC | 4.4% |
|
ELI LILLY & CO | 3.4% |
|
DANAHER CORP | 2.9% |
|
INTUITIVE SURGICAL INC | 2.6% |
 |
NOVO NORDISK A/S-B | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
JOHNSON & JOHNSON | 2.1% |
|
IQVIA HOLDINGS INC | 2.1% |
JDOC Underweight Relative to CANC
|
GENMAB A/S SPONSORED ADR | -5.7% |
|
REVOLUTION MEDICINES, INC. | -5.2% |
|
COGENT BIOSCIENCES INC | -4.5% |
|
HALOZYME THERAPEUTICS INC | -3.8% |
|
BEIGENE LTD. SPONSORED ADR | -3.7% |
|
EXELIXIS INC | -3.6% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.1% |
|
CG ONCOLOGY, INC. | -2.4% |
|
ENLIVEN THERAPEUTICS, INC. | -2.4% |
|
BRIDGEBIO PHARMA, INC. | -2.3% |